Central Texas Guide to Rare Neuro Updates, Advocacy, and Support

Table of Contents

  1. 📝 Editor's Note: Return to Needle Land

  2. đź“° Main Article: Texas Voters to Decide on $3 Billion Dementia Research Institute

  3. 🧬 CIDP Focus: Texas Treatment Centers & Current Clinical Trials

  4. ⚡ Clinical Trial Spotlight: CIDP Trial Enrollment Guide

  5. đź’ˇ Resource Spotlight: New Texas Patient Support Programs

  6. 🔬 Innovation Watch: UT Southwestern's $5M Cerebellar Research

  7. 🌵 Closing Thoughts: Building Networks Across Rural Texas

  8. đź“… Future Topics: What's Coming

1. Editor's Note: Needles in my future 🌵

Real talk from someone who's been in the trenches with you—I'm writing this edition while dealing with what I now call "The Weaks." After a “set” of infusions and taking a 4-month break with my fingers crossed, CIDP has decided to remind me exactly who's boss. Arms and legs feeling like they're made of lead? Check. Normal to “ I need to sit down” in moments? Check. Need a pot of coffee to keep going? Double check. I really hate the word relapse, so lets just say I now have a new unwanted guest that drops in uninvited, stays a few hours and then like a bad headache we are glad to see him go.

But here's the thing about our rare disease community—we don't just survive these moments, we learn from them, share them, and somehow find ways to keep moving forward (even when "moving forward" feels like wading through molasses). Every story in this newsletter, every resource we share, every connection we make—it all comes from this real, messy, experience of living with conditions that most folks have never heard of.

So if you're reading this while dealing with your own version of "The Weaks," know that you're not alone. We're all figuring this out together, one infusion, one bad day, one small victory at a time.

Stay strong, Texas.

2. đź“° MAIN ARTICLE

Texas Voters Hold Key to $3 Billion Brain Research Revolution

November's election offers Texas families a chance to create the world's largest brain health research center. The Dementia Prevention and Research Institute of Texas (DPRIT) awaits voter approval for $3 billion in funding, awarding up to $300 million annually through grants.

With nearly half a million Texans affected by dementia and $4 billion in annual Medicare costs, DPRIT will research all brain diseases—including Parkinson's and rare neurological disorders. Following the success of Texas' Cancer Prevention and Research Institute, which recruited 324 researchers and supported 74 companies, this initiative could revolutionize rare disease research statewide.

3. 🧬 CIDP FOCUS

Texas CIDP Resources & Active Clinical Opportunities

CIDP affects approximately 30,000 Americans with progressive weakness and sensory impairment in arms and legs. Texas offers comprehensive care through UTHealth Houston's McGovern Medical School Neuromuscular Program and multiple active clinical trials. Current opportunities include the ARISE study for newly diagnosed and treatment-experienced patients, riliprubart Phase 3 trials (MOBILIZE/VITALIZE) testing immune system blockers, and NVG-2089 Phase 2 for treatment-refractory cases. Early treatment is crucial, with up to 4 in 5 people responding well to therapy. Texas GBS/CIDP Foundation chapters provide ongoing support statewide.

đź”— Key Resources:

4. ⚡ CLINICAL TRIAL SPOTLIGHT

CIDP Trial Enrollment Opportunities

Multiple breakthrough CIDP trials actively recruit across Texas, offering alternatives to traditional treatments. All qualifying participants receive study-required medical care at no cost, with travel expense compensation available.

Current Texas Trials:

  • ARISE Study: Open to all CIDP patients

  • Riliprubart Studies: Subcutaneous or IV options

  • CAPTIVATE (DNTH103): Novel treatment approach

đź”— Find trials: GBS/CIDP Foundation Clinical Trials

5. đź’ˇ RESOURCE SPOTLIGHT

New Texas Patient Support Programs

UT Southwestern earned designation as the North Texas Alzheimer's Disease Research Center with $23 million in five-year funding. This creates opportunities for patients with various neurodegenerative conditions through research participation, virtual support groups, and travel assistance programs.

6. 🔬 INNOVATION WATCH

$5M UT Southwestern Cerebellar Research Breakthrough

Dallas researchers received up to $5 million from the Raynor Cerebellum Project to develop neuromodulation therapies for cerebellar disorders. The goal: implantable therapy allowing patients to "live their lives rather than keep coming back for repeated treatments."

7. 🌵 CLOSING THOUGHTS

Building Networks Across Rural Texas

Texas rare disease innovation spans from major cities to rural communities. The upcoming DPRIT election gives every Texan a voice in advancing brain health research. Whether in Houston or small-town Texas, your vote could accelerate treatments for rare neurological diseases affecting thousands of families statewide.

8. đź“… COMING UP

  • Election results: What DPRIT approval means for Texas families

  • Houston Methodist neural restoration breakthroughs

  • Patient advocacy spotlight from East Texas

  • Latest CIDP trial results and new study openings

Neighborly Note & Disclaimer: We share research and lived experience, but we’re not doctors—always check with your provider. Stories stay anonymous unless you say otherwise. Sponsors don’t guide content. Found an error? Tell us. We strive for accuracy, and your feedback keeps us honest.

Keep Reading

No posts found